Federal Rescheduling of Cannabis: An Expert Panel
February 9, 2026
12:30 pm - 1:30 pm
Zoom
In late 2025, President Trump signed an Executive Order to expedite the rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act.
If finalized, the reclassification would mark a significant policy shift with concrete legal, economic, and research implications. What does this mean for recreational/medical use, state and federal drug law, and cannabis research?
Our panel of experts bring multidisciplinary perspectives to this complicated issue.